CellCarta and Imagene AI expanded an AI pathology partnership aimed at moving biomarker assays into clinical development and companion diagnostic (CDx) pathways. The collaboration covers analytical validation, clinical deployment, and regulatory support, including programs in non-small cell lung cancer that use Imagene AI’s Lung Prediction Panel to support global trial and submission activities.